A bioassay system for pharmacological standardization of Withania somnifera derived herbal remedies
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Contents of bioactive substances extractable from different parts of terrestrial plants vary enormously. Aim: To ascertain that parts of Withania somnifera other than its roots can also be used for prevention and cure of unavoidable stress triggered central hypersensitivity to pain. Material and Methods: Groups of male or female mice treated either with Withania somnifera extracts or with metformin, aspirin, imipramine, diazepam and niacin for 11 consecutive days were subjected to “foot-shock stress-induced hyperthermia” and “hot plate” tests on the 1st, 5th, 7th, and 10th days of the experiments. On the 11th day, they were subjected to tail suspension test and on 12th day pentobarbital hypnosis test. Results: Except for diazepam and imipramine, protective effects of all other tested drugs as well as of the Withania somnifera extracts against stress-induced central hypersensitivity to pain were accompanied by their preventive effects against foot-shock stress-induced body weight losses. All observed stress response suppressing effects of all test agents increased with increasing numbers of treatment days. However, mean duration of pentobarbital-induced sleep was shorter in the extracts treated groups and longer in the diazepam treated ones only. Conclusions: Reported observations reveal that pharmacological activity profile of Withania somnifera extracts in male and female mice are almost identical, and are not like those of several drugs currently often prescribed for the treatment of diabetes-associated comorbidities. Withanolides are not the only extractable bioactive constituents of Withania somnifera. The described bioassay system is well suited for pharmacological standardization of diverse types of Withania somnifera extracts.
Abstract
Background: Contents of bioactive substances extractable from different parts of terrestrial plants vary enormously. Aim: To ascertain that parts of Withania somnifera other than its roots can also be used for prevention and cure of unavoidable stress triggered central hypersensitivity to pain. Material and Methods: Groups of male or female mice treated either with Withania somnifera extracts or with metformin, aspirin, imipramine, diazepam and niacin for 11 consecutive days were subjected to “foot-shock stress-induced hyperthermia” and “hot plate” tests on the 1st, 5th, 7th, and 10th days of the experiments. On the 11th day, they were subjected to tail suspension test and on 12th day pentobarbital hypnosis test. Results: Except for diazepam and imipramine, protective effects of all other tested drugs as well as of the Withania somnifera extracts against stress-induced central hypersensitivity to pain were accompanied by their preventive effects against foot-shock stress-induced body weight losses. All observed stress response suppressing effects of all test agents increased with increasing numbers of treatment days. However, mean duration of pentobarbital-induced sleep was shorter in the extracts treated groups and longer in the diazepam treated ones only. Conclusions: Reported observations reveal that pharmacological activity profile of Withania somnifera extracts in male and female mice are almost identical, and are not like those of several drugs currently often prescribed for the treatment of diabetes-associated comorbidities. Withanolides are not the only extractable bioactive constituents of Withania somnifera. The described bioassay system is well suited for pharmacological standardization of diverse types of Withania somnifera extracts.
참고문헌 (46)
- Alam N, "High catechin concentrations detected in Withania somnifera(ashwagandha)by high performance liquid chromatography analysis", BMC Complement Altern Med, 11(1), pp.65~ (2011)
- Ameh SJ, "Herbal Drug Development from Traditional Formulations : Refoc using Pharmaceutics and Posology for Accelerated Validation", Brit J Pharm Res, 4(12), pp.1451~1476 (2014)
- Andrew R, "Principles of pharmacological research of nutraceuticals", Br J Pharmacol, 174(11), pp.1177~1194 (2017)
- Balasubramani SP, "Plant based Rasayana drugs from Ayurveda", Chin J Integr Med, 17(2), pp.88~94 (2011)
- Berk M, "Aspirin : a review of its neurobiological properties and therap eutic potential for mental illness", BMC Med, 11, pp.74~ (2013)
- Bharti SK, "Application of HR MAS NMR spectroscopy for studying chemotype variations of Withania somnifera (L.) Dunal", Magn Reson Chem, 49(10), pp.659~667 (2011)
- B hatia A, "Metabolic profiling for studying chemotype variations in Withania somnifera (L.) Dunal fruits using GC MS and NMR spectroscopy", Phytochemistry, 93, pp.105~115 (2013)
- Can A, "The tail suspe nsion test", J Vis Exp, 59, pp.37~69 (2012)
- Chatterjee S, "Comprehensive metabolic fingerprinting of Withania somnifera leaf and root extracts", Phytochemistry, 71(10), pp.1085~1094 (2010)
- Chatterjee SS, "Quantitative Systems Pharmacology : Lessons from Fumaric acid and Herbal Remedies", Drug Designing, 6(152), pp.1~9 (2017)
- Dar NJ, "Pharmacologic overview of Withania somnifera t he Indian Ginseng", Cell Mol Life Sci, 72, pp.4445~4460 (2015)
- Amitabha Dey, "Analgesic activity of a Withania somnifera extract in stressed mice", Oriental Pharmacy and Experimental Medicine, 16(4), pp.295~302 (2016), 융합한의과학연구소[DOI]
- Dey A, "Low dose effects of a Wit hania somnifera extract on altered marble burying behavior in stressed mice", J Intercult Ethnopharmacol, 5(3), pp.274~277 (2016)
- Hankin BL, "Development of gender differences in depression : An elaborated cognitive vulnerability transactional stres s theory", Psychol Bull, 127(6), pp.773~796 (2001)
- Kaushik MK, "Triethylene glycol, an active component of Ashwagandha (Withania somnifera) leaves, is responsible for sleep induction", PLoS One, 12(2), pp.e0172508~ (2017)
- Kh an SA, "Low dose aspirin like analgesic and anti inflammatory activities of mono hydroxybenzoic acids in stressed rodents", Life Sci, 148, pp.53~62 (2016)
- Dempsey DA, "How does the multifaceted plant hormone salicylic acid comb at disease in plants and are similar mechanisms utilized in humans?", BMC Biol, 15(1), pp.23~ (2017)
- Kumar A, "Morphological and chemical variation in 25 collections of the Indian medicinal plant, Withania somnifera (L.) Dunal (Solanaceae)", Genet Resour Crop Evol, 54(3), pp.655~660 (2007)
- Kumar V, "Science of Ashwagandha: Preventive and Therapeutic Potentials", pp.37~68 (2017), Springer International Publishing
- Vikas Kumar, "Chemistry and pharmacology of withania somnifera: An update", 셀메드, 5(1), pp.1~1 (2015), 셀메드 세포교정의약학회[DOI]
- Vikas Kumar, "Potential of some traditionally used edible plants for prevention and cure of diabesity associated comorbidities", 셀메드, 5(2), pp.8~8 (2015), 셀메드 세포교정의약학회[DOI]
- Mathur R, "Medicinal plant based health products : Where is the medicinal constit uent?", Indian J Pharmacol, 41(4), pp.205~206 (2009)
- Murthy HN, "Establishment of Withania somnifera hairy root culture s for the production of withanolide A", J Integr Plant Biol, 50(8), pp.975~981 (2008)
- Ojima K, "Hyperactivity of central noradrenergic and CRF system is involved in social isolation induced decrease in pentobarbital sleep", Brain Res, 684(1), pp.87~94 (1995)
- Olff M, "Gender differences in posttraumatic stress disorder", Psychol Bull, 133(2), pp.183~204 (2007)
- Orrù A, "Withania somnifera (L.) Dunal root extract alleviates formalin induced nociception in mice: involvement of the opioidergic system", Behav Pharmacol, 27(1), pp.57~68 (2016)
- Pal A, "Antioxidant and free radical scavenging activity of Ashwagandha (Withania somnifera L.) leaves", Journal of Global Biosciences, 4(1), pp.1127~1137 (2015)
- Pratibha C, "Therapeutic Properties and Significance of Different parts of Ashwagandha A Medicinal Plant", International Journal of Pure & Applied Bioscience, 1(6), pp.94~101 (2013)
- Rahola JG, "Somatic drugs for psychiatric diseases : aspirin or simvastatin for depression?", Curr Neuropharmacol, 10(2), pp.139~158 (2012)
- Rai M, "Anticancer activities of Withania somnifera : Current research, formulations, and fu ture perspectives", Pharm Biol, 54(2), pp.189~197 (2016)
- Rauniyar BK, "Anti Stress Activity of Phloroglucinol : A Transient Metabolite of Some Plant Polyph enolics", Pharmacologia, 6, pp.21~30 (2015)
- Rayees S, "Science of Ashwagandha: Preventive and Therapeutic Potentials", pp.81~103 (2017), Springer International Publishing
- Sangwan RS, "Phytochemical variability in commercial herbal products and preparations of Withania somnifera(Ashwagandha)", Curr Sci, 86(3), pp.461~465 (2004)
- Shrivastava N, "Adaptogenic Potential of Triethylene Glycol and Quercetin in Stresse d Mice", Pharm Pharmacol Int J, 2(6), pp.197~206 (2015)
- Singh B, "Adaptogenic activity of a novel withanolide free aqueous fraction from the roots of Withania somnifera Dun. (Part II)", Phytother Res, 17, pp.531~536 (2003)
- Singh B, "Adaptogenic activity of a novel, withanolide free aqueous fraction from the roots of Withania somnifera Dun", Phytother Res, 15, pp.311~318 (2001)
- Singh N, "Ashwagandha, An overview on ashwagandha: a Rasayana (rejuvenator) of Ayurveda", Afr J Tradit Complement Altern Med, 8(5 Suppl), pp.208~213 (2011)
- Thakur AK, "Reverse A yurvedic pharmacology of Ashwagandha as an adaptogenic anti diabetic plant : a pilot study", Curr Trad Med, 1, pp.51~61 (2015)
- Turner RA., "Screening methods in pharmacology", pp.100~102 (1965), Academic Press
- Virk JK, "Lack of pharmacological basis of substitution of an endangered plant group Ashtawarga A significant ingredient of polyherbal formulations", American Journal of Phytomedicine and Clinical Therapeutics, 2, pp.690~712 (2015)
- Virk JK, "Ashtawarga plants Suffering a triple standardization syndrome", J Tradit Complement Med, 7(4), pp.392~399 (2017)
- Wadhwa R, "Water extract of Ashwagandha leaves has anticancer activity: identification of an active component and its mechanism of action", PLoS One, 8(10), pp.e77189~ (2013)
- Winston D, "Adaptogens: Herbs for Strength, Stamina, and Stress Relief" (2007), Inner Traditions Bear & Co
- Muhammad B. Yunus, "Fibromyalgia and Overlapping Disorders: The Unifying Concept of Central Sensitivity Syndromes", Seminars in Arthritis and Rheumatism, 36(6), pp.339~356 (2007), Elsevier BV[DOI]
- Yunus MB, "Thematic issue : an update on central sensitivity syndromes and the issues of nosology and psychobiology", Curr Rheumatol Rev, 11(2), pp.70~85 (2015)
- Zhou J, "Trigonelline : a plant alkaloid with therapeutic potential for diabetes and centra l nervous system disease", Curr Med Chem, 19(21), pp.3523~3531 (2012)